Bafna Pharmaceuticals Ltd

NSE: BAFNAPH · BSE: 532989 · Pharmaceuticals & Biotechnology · 10 announcements

Share price: ₹401.85
Market cap: ₹950.6 Cr
Revenue (annual): ₹150.6 Cr
Net profit (annual): ₹11.10 Cr
P/E (TTM): 122.1×Sector 47.3×
Promoter holding: 75.00%+0.00% QoQ
FII holding: 9.34%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Financial Results 3 Board Meeting Date 2 Annual General Meeting 2 Price Movement Clarification 1 Other Announcement 1 Annual Report 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

2 announcements with these filters

5 Aug 2026 17:01 IST BSE

Board Meeting Date

Bafna Pharmaceuticals Board Meeting Date

Bafna Pharmaceuticals has scheduled a board meeting for August 11, 2026, to consider and approve the unaudited financial results for the quarter ended June 30, 2026.

Read the filing ↗

21 May 2026 17:58 IST BSE

Board Meeting Date

Bafna Pharmaceuticals Board Meeting Date

Bafna Pharmaceuticals scheduled a board meeting for May 29, 2026, to approve audited financial results. The trading window remains closed until May 31, 2026.

Read the filing ↗